Veracyte Completes NIGHTINGALE Clinical Utility Trial Enrollment for Percepta Nasal Swab Lung Cancer Test

Veracyte Completes NIGHTINGALE Clinical Utility Trial Enrollment for Percepta Nasal Swab Lung Cancer Test

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–$VCYT—Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced it…

Continue Reading
Breakthrough Nanobody Tech Hits Lung Cancer Cells Like a Drone Strike

Breakthrough Nanobody Tech Hits Lung Cancer Cells Like a Drone Strike

A nanobody-based technology can precisely identify and attack lung cancer cells—sparing surrounding healthy tissue. This is…

Continue Reading
Nanobody breakthrough offers precise targeting of lung cancer cells

Nanobody breakthrough offers precise targeting of lung cancer cells

A research team led by Dr. Juyeon Jung at the Bio-Nano Research Center, Korea Research Institute…

Continue Reading
Veracyte Completes NIGHTINGALE Clinical Utility Trial Enrollment for Percepta Nasal Swab Lung Cancer Test

Lung Cancer Research Foundation Expands Scientific Advisory Board

Foundation welcomes leaders in lung cancer research to achieve strategic objectives NEW YORK, Aug. 19, 2025…

Continue Reading
Global Healthcare Innovator Qure.ai Expands Executive Team With Eminent Lung Health Appointment to Accelerate Clinical Strategy | Region

Global Healthcare Innovator Qure.ai Expands Executive Team With Eminent Lung Health Appointment to Accelerate Clinical Strategy | Region

NEW YORK–(BUSINESS WIRE)–Aug 20, 2025– Qure.ai has appointed Dr. Javier J. Zulueta, previously Professor of Medicine…

Continue Reading
Mission Moment August 2025 | American Lung Association

Mission Moment August 2025 | American Lung Association

YOUR HEALTH New Campaign Educates People About Lung Nodules We recently launched a new campaign, in…

Continue Reading